Published in J Pediatr on November 01, 1990
Hyperphosphatasemia in GM1 gangliosidosis. J Pediatr (1992) 0.75
PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med (2001) 6.09
A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell (2001) 5.76
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene (1993) 3.08
Maturation of neuroblastoma cells in the presence of dimethylsulfoxide. Proc Natl Acad Sci U S A (1976) 2.93
Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest (2000) 2.67
Isodisomy of chromosome 7 in a patient with cystic fibrosis: could uniparental disomy be common in humans? Am J Hum Genet (1989) 2.43
Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Neurology (1998) 2.39
Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat Genet (2000) 2.39
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet (1997) 2.28
A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res (1995) 2.23
In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proc Natl Acad Sci U S A (1970) 2.22
The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet (1983) 2.15
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88
Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis. Arch Dermatol (1995) 1.88
Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J (1996) 1.82
Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes. EMBO J (1993) 1.77
Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study. Arch Neurol (2000) 1.69
Can we rely on the family history? Am J Med Genet (1998) 1.61
Mucolipidosis type IV: clinical spectrum and natural history. Pediatrics (1987) 1.59
Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology (1999) 1.49
Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Arch Gen Psychiatry (2001) 1.48
A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group. Int J Geriatr Psychiatry (2000) 1.47
Congenital juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha-2. Med Pediatr Oncol (1993) 1.42
Nose tapping test inducing a generalized flexor spasm: a hallmark of hyperexplexia. Acta Paediatr Scand (1991) 1.40
Cleft lip and palate, pili torti, malformed ears, partial syndactyly of fingers and toes, and mental retardation: a new syndrome? J Med Genet (1987) 1.40
Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry (2003) 1.28
Two different connexin 26 mutations in an inbred kindred segregating non-syndromic recessive deafness: implications for genetic studies in isolated populations. Hum Mol Genet (1997) 1.18
Effect of chromate stress on Escherichia coli K-12. J Bacteriol (2006) 1.18
Early enteral feeding and nosocomial sepsis in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed (2004) 1.12
Homozygosity mapping of achromatopsia to chromosome 2 using DNA pooling. Hum Mol Genet (1997) 1.11
Asplenia and polysplenia syndromes with abnormalities of lateralisation in a sibship. J Med Genet (1981) 1.11
Multiple mutations are responsible for the high frequency of metachromatic leukodystrophy in a small geographic area. Am J Hum Genet (1995) 1.10
Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult Scler (2007) 1.10
Multiple mutations in a specific gene in a small geographic area: a common phenomenon? Am J Hum Genet (1996) 1.08
Two different mutations are responsible for Krabbe disease in the Druze and Moslem Arab populations in Israel. Hum Genet (1996) 1.07
Localization of the Krabbe disease gene (GALC) on chromosome 14 by multipoint linkage analysis. Am J Hum Genet (1993) 1.07
Molecular genetics of metachromatic leukodystrophy. Hum Mutat (1994) 1.05
Combined enzymatic and linkage analysis for heterozygote detection in Hunter syndrome: identification of an apparent case of germinal mosaicism. Am J Med Genet (1993) 1.03
Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts. J Clin Oncol (1991) 1.03
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood (2000) 1.03
Transient neonatal diabetes mellitus in a child with invdup(6)(q22q23) of paternal origin. Eur J Hum Genet (1998) 1.01
Chediak-Higashi syndrome. Am J Pediatr Hematol Oncol (1987) 1.01
Hunter's syndrome: activity of iduronate sulfate sulfatase in the serum of pregnant heterozygotes. N Engl J Med (1984) 1.00
Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon. Exp Hematol (1991) 0.99
Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry (2000) 0.99
hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21. Mol Psychiatry (1999) 0.99
Intracranial meningiomas: correlation of peritumoral edema and psychiatric disturbances. Psychiatry Res (1995) 0.99
Krabbe disease: increased incidence in a highly inbred community. Am J Med Genet (1985) 0.99
Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. J Basic Clin Physiol Pharmacol (1995) 0.98
Sleep disturbances in children with attention-deficit/hyperactivity disorder: a comparative study with healthy siblings. J Learn Disabil (1998) 0.98
Latent viruses and Bell's palsy in children. Eur Neurol (1978) 0.97
Influence of Volatile Fatty Acids on Nitrite Accumulation by a Pseudomonas stutzeri Strain Isolated from a Denitrifying Fluidized Bed Reactor. Appl Environ Microbiol (1996) 0.97
Late-onset multiple sclerosis. J Am Geriatr Soc (2001) 0.97
Dermoid cysts, hypothyroidism, cleft palate, and hypodontia. J Clin Dysmorphol (1983) 0.96
Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry (1995) 0.95
Liposomal amphotericin B (AmBisome) in the treatment of neonatal candidiasis in very low birth weight infants. Infection (2000) 0.95
Both recessive and dominant forms of anhidrotic/hypohidrotic ectodermal dysplasia map to chromosome 2q11-q13. Am J Hum Genet (1999) 0.94
Identification of a prevalent founder mutation in an Israeli Muslim Arab village confirms the role of PRCD in the aetiology of retinitis pigmentosa in humans. J Med Genet (2010) 0.94
Heterozygote detection in Hunter syndrome. Am J Med Genet (1984) 0.93
On the inheritance of primary spontaneous pneumothorax. Am J Med Genet (1991) 0.92
Heterogeneity of the autosomal dominant split hand/split foot malformation. Am J Hum Genet (1995) 0.92
The genetics of the aryl sulfatase A locus. Am J Hum Genet (1981) 0.92
Genetic homogeneity of autoimmune polyglandular disease type I. Am J Hum Genet (1996) 0.92
Use of lasers in assisted fertilization and hatching. Hum Reprod (1994) 0.92
Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients. Int Clin Psychopharmacol (2004) 0.91
Sleep disturbances, fibromyalgia and primary Sjögren's syndrome. Clin Exp Rheumatol (1997) 0.91
Familial café au lait spots: a variant of neurofibromatosis type 1. J Med Genet (1995) 0.91
Machado-Joseph disease: correlation between the clinical features, the CAG repeat length and homozygosity for the mutation. Eur J Hum Genet (1996) 0.90
Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients. Br J Haematol (2000) 0.90
The femur, fibula, ulna (FFU) complex in siblings. Clin Genet (1983) 0.90
A gene for premature ovarian failure associated with eyelid malformation maps to chromosome 3q22-q23. Am J Hum Genet (1996) 0.90
A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry (1996) 0.89
Autosomal dominant inheritance of Klein-Waardenburg syndrome. Am J Med Genet (1992) 0.89
High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates. Eur J Clin Microbiol Infect Dis (2003) 0.89
The effects of a connexin 26 mutation--35delG--on oto-acoustic emissions and brainstem evoked potentials: homozygotes and carriers. Hear Res (2002) 0.89
Otoacoustic emissions and brainstem evoked potentials in compound carriers of connexin 26 mutations. Hear Res (2003) 0.89
In vitro induction of myeloid proliferation and maturation in infantile genetic agranulocytosis. Blood (1971) 0.89
Metachromatic leukodystrophy in the habbanite Jews: high frequency in a genetic isolate and screening for heterozygotes. Am J Hum Genet (1980) 0.89
Pyoderma gangrenosum and sterile multifocal osteomyelitis preceding the appearance of Takayasu arteritis. Pediatr Dermatol (1995) 0.88
Syndactyly, ectodermal dysplasia, and cleft lip and palate. J Med Genet (1988) 0.88
T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients. Clin Immunol (2004) 0.88
Response of neonatal hypocalcaemia to 1 alpha-hydroxyvitamin D3. Arch Dis Child (1979) 0.87
Hunter syndrome among Ashkenazi Jews in Israel; evidence for prenatal selection favoring the Hunter allele. Hum Genet (1985) 0.87
Cognitive changes in early MS: a call for a common framework. J Neurol Sci (2006) 0.87
Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a diagnostic tool. Am J Med Genet (1994) 0.87
Crohn's disease in Ashkenazi Jews. Gastroenterology (1990) 0.87
Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. J Neurol Neurosurg Psychiatry (2005) 0.86
Abnormal liver test results in myotonic dystrophy. J Clin Gastroenterol (1998) 0.86
Familial situs inversus and congenital heart defects. Am J Med Genet (1987) 0.86
Isochromosome 18p in a mother and her child. Am J Med Genet (1993) 0.86
Genetic heterogeneity in Gaucher disease. J Med Genet (1986) 0.85
Increased anti-Sm antibodies in schizophrenic patients and their families. Prog Neuropsychopharmacol Biol Psychiatry (1993) 0.85
Triple mosaicism 45,XY,--18/46, XY/47,XY,+18. J Med Genet (1979) 0.84
Behr's syndrome and 3-methylglutaconic aciduria. Am J Ophthalmol (1992) 0.84
Resting energy expenditure in patients with thalassemia major. Am J Clin Nutr (1995) 0.84
Sepsis at a neonatal intensive care unit: a four-year retrospective study (1989-1992). Isr J Med Sci (1997) 0.84